China, Macao Special Administrative Region vs Niger: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
China, Macao Special Administrative Region
0.1%
in 2024
Niger
3.2%
in 2024
China, Macao Special Administrative Region rank
2nd
Niger rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- China, Macao Special Administrative Region
- Niger
How they compare
Niger currently reports 3.2% against 0.1% in China, Macao Special Administrative Region, a difference of 3.1%.
That makes Niger's figure about 32.0 times China, Macao Special Administrative Region's.
Across all 10 years both countries report, Niger has been ahead every year.
China, Macao Special Administrative Region ranks 2nd and Niger ranks 3rd of 4 groups.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China, Macao Special Administrative Region | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 2.6% | 2.5% | Niger |
| 2020s | 0.1% | 3.4% | 3.3% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, China, Macao Special Administrative Region or Niger?
- Niger, at 3.2% against 0.1% in China, Macao Special Administrative Region as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between China, Macao Special Administrative Region and Niger?
- 3.1%, with Niger ahead.
- How many years of comparable data are there for China, Macao Special Administrative Region and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do China, Macao Special Administrative Region and Niger rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- China, Macao Special Administrative Region ranks 2nd and Niger ranks 3rd of 4 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.